5,532 Shares in Tenet Healthcare Corporation $THC Purchased by Winnow Wealth LLC

Winnow Wealth LLC acquired a new position in Tenet Healthcare Corporation (NYSE:THC) in the third quarter, according to the company in its most recent filing with the SEC. The firm acquired 5,532 shares of the company’s stock, valued at approximately $1,129,000. Tenet Healthcare accounts for approximately 0.9% of Winnow Wealth LLC’s portfolio, making the stock its 28th biggest position.

A number of other institutional investors have also recently bought and sold shares of the business. AlphaQuest LLC boosted its position in shares of Tenet Healthcare by 238.3% during the 3rd quarter. AlphaQuest LLC now owns 5,965 shares of the company’s stock valued at $1,211,000 after acquiring an additional 4,202 shares in the last quarter. Fidelis Capital Partners LLC bought a new position in Tenet Healthcare during the third quarter worth about $218,000. Truist Financial Corp grew its stake in shares of Tenet Healthcare by 12.9% in the 3rd quarter. Truist Financial Corp now owns 11,669 shares of the company’s stock valued at $2,369,000 after purchasing an additional 1,335 shares during the period. Alta Wealth Advisors LLC acquired a new stake in Tenet Healthcare in the 3rd quarter valued at $474,000. Finally, Belpointe Asset Management LLC grew its position in Tenet Healthcare by 19.5% in the third quarter. Belpointe Asset Management LLC now owns 3,658 shares of the company’s stock valued at $743,000 after acquiring an additional 596 shares during the period. Institutional investors and hedge funds own 95.44% of the company’s stock.

Insider Transactions at Tenet Healthcare

In other Tenet Healthcare news, Director Tammy Romo sold 15,099 shares of the stock in a transaction dated Monday, November 3rd. The stock was sold at an average price of $200.81, for a total value of $3,032,030.19. Following the completion of the sale, the director directly owned 47,267 shares in the company, valued at $9,491,686.27. This represents a 24.21% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Nadja West sold 2,178 shares of the business’s stock in a transaction that occurred on Monday, December 15th. The shares were sold at an average price of $197.47, for a total value of $430,089.66. Following the completion of the transaction, the director owned 28,480 shares of the company’s stock, valued at $5,623,945.60. This represents a 7.10% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 43,000 shares of company stock valued at $8,725,996 over the last three months. 0.81% of the stock is currently owned by corporate insiders.

Tenet Healthcare Trading Down 0.0%

NYSE:THC opened at $189.48 on Friday. The firm has a market capitalization of $16.65 billion, a price-to-earnings ratio of 12.99, a PEG ratio of 0.81 and a beta of 1.41. Tenet Healthcare Corporation has a 1-year low of $109.82 and a 1-year high of $222.82. The business’s 50-day moving average price is $200.90 and its two-hundred day moving average price is $191.89. The company has a current ratio of 1.71, a quick ratio of 1.64 and a debt-to-equity ratio of 2.27.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings results on Tuesday, October 28th. The company reported $3.70 earnings per share for the quarter, beating analysts’ consensus estimates of $3.33 by $0.37. The business had revenue of $5.29 billion for the quarter, compared to the consensus estimate of $5.26 billion. Tenet Healthcare had a net margin of 6.49% and a return on equity of 25.11%. Tenet Healthcare’s revenue for the quarter was up 3.2% on a year-over-year basis. During the same period last year, the company posted $2.93 EPS. On average, equities analysts expect that Tenet Healthcare Corporation will post 12.24 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on THC shares. Cantor Fitzgerald increased their target price on shares of Tenet Healthcare from $190.00 to $245.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 29th. Weiss Ratings raised shares of Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a report on Monday, December 29th. Morgan Stanley reaffirmed an “overweight” rating and issued a $247.00 target price on shares of Tenet Healthcare in a research note on Thursday, December 18th. KeyCorp raised their price target on shares of Tenet Healthcare from $205.00 to $225.00 and gave the company an “overweight” rating in a report on Wednesday, October 8th. Finally, Guggenheim increased their price objective on Tenet Healthcare from $238.00 to $257.00 and gave the company a “buy” rating in a research report on Tuesday, December 2nd. One investment analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $233.81.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.